Private Market View

Bayer

Seoul, South Korea · Founded 2022 · Privately Held (backing)

Last price · $/share
Implied valuation
Total raised
$10K
Last round

Key facts

  • It has raised $10K; the latest was Early Stage VC ($10K) in Aug 2025.
  • Notable investors include KB Investment.
  • Status: Privately Held (backing).

Investors

1
Free account
See the evidence behind this price
  • ·The complete investor list — 1 names
  • ·Watchlist + deal alerts for Bayer
  • ·The full record, as it builds
Create free account
No card required

Funding rounds

No rounds on record

No funding rounds for Bayer are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.

Pro members can request priority coverage with a 48-hour turnaround.

About Bayer

Operator of social welfare coordination systems intended for household care support. The company facilitates personalized benefit estimation, real-time eligibility assessment, integrated service scheduling, digital onboarding, and secure communication between users and care advisors, enabling families and individuals in urban regions to access tailored financial assistance, streamline caregiving logistics, and manage welfare-related interactions with improved transparency and efficiency.

Sector
Consumer Products and Services (B2C)
HQ
Seoul, South Korea
Founded
2022
Employees
13
Website
byl.im/
Ownership
Privately Held (backing)
PA Mark — not yet priced

Bayer doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.

Pro members can request priority coverage with a 48-hour turnaround.

Recorded secondary trades

No prints on record

No secondary trades in Bayer shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.

Pro members can request priority coverage with a 48-hour turnaround.

Institutional fund marks

No fund marks yet

No SEC-registered fund has reported a fair-value mark on Bayer in its N-PORT filings yet. We sweep new filings monthly.

Pro members can request priority coverage with a 48-hour turnaround.